Next Article in Journal
European Center for Nanotoxicology – Nanoscale Materials: A New Challenge for Toxicology
Previous Article in Journal
Transport Studies of Nanostructured Materials across the Buccal Mucosa
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 78
Issue 3
10.3797/scipharm.cespt.8.LNT05
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Conference Report

A Model for Studying Nasal Drug Delivery: RPMI 2650 Human Nasal Epithelial Cell Line

by
L. KÜRTI
1,2,*,
L. KIS
1,2,
S. VESZELKA
2,
P. SZABÓ-RÉVÉSZ
1 and
M. A. DELI
2
1
Department of Pharmaceutical Technology, University of Szeged, Szeged, Hungary
2
Laboratory of Molecular Neurobiology, Institute of Biophysics, Biological Research Center, Hungarian Academy of Sciences, Szeged, Hungary
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2010, 78(3), 579; https://doi.org/10.3797/scipharm.cespt.8.LNT05
Submission received: 12 July 2010 / Accepted: 12 July 2010 / Published: 12 July 2010
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Studies on nasal epithelial models are important to develop vehicles for systemic nasal drug delivery, and also for targeting drugs to brain via the nasal route. [...]

Share and Cite

MDPI and ACS Style

KÜRTI, L.; KIS, L.; VESZELKA, S.; SZABÓ-RÉVÉSZ, P.; DELI, M.A. A Model for Studying Nasal Drug Delivery: RPMI 2650 Human Nasal Epithelial Cell Line. Sci. Pharm. 2010, 78, 579. https://doi.org/10.3797/scipharm.cespt.8.LNT05

AMA Style

KÜRTI L, KIS L, VESZELKA S, SZABÓ-RÉVÉSZ P, DELI MA. A Model for Studying Nasal Drug Delivery: RPMI 2650 Human Nasal Epithelial Cell Line. Scientia Pharmaceutica. 2010; 78(3):579. https://doi.org/10.3797/scipharm.cespt.8.LNT05

Chicago/Turabian Style

KÜRTI, L., L. KIS, S. VESZELKA, P. SZABÓ-RÉVÉSZ, and M. A. DELI. 2010. "A Model for Studying Nasal Drug Delivery: RPMI 2650 Human Nasal Epithelial Cell Line" Scientia Pharmaceutica 78, no. 3: 579. https://doi.org/10.3797/scipharm.cespt.8.LNT05

APA Style

KÜRTI, L., KIS, L., VESZELKA, S., SZABÓ-RÉVÉSZ, P., & DELI, M. A. (2010). A Model for Studying Nasal Drug Delivery: RPMI 2650 Human Nasal Epithelial Cell Line. Scientia Pharmaceutica, 78(3), 579. https://doi.org/10.3797/scipharm.cespt.8.LNT05

Article Metrics

Back to TopTop